| EN

ZAILIKE®:Arbidol Hydrochloride dispersible tablets

ZAILIKE®:Arbidol Hydrochloride dispersible tablets

Indications:

In the treatment of upper respiratory tract infections caused by the influenza A or B virus.

Arbidol is a hemagglutinin fusion inhibitor and was proven to be effective against viruses resistant to oseltamivir, a neuraminidase inhibitor. It is a broad-spectrum anti-viral for treatment of influenza.

Arbidol is recommended by the NHC in its Guidelines for the Diagnosis and Treatment of Influenza (2019 Edition) (《流行性感冒诊疗方案(2019年版)) and Guidelines for the Diagnosis and Treatment of COVID-19 (Sixth/Seventh Editions for Trial Implementation) (《新冠肺炎诊疗方案(试行第六版、第七版)).

Arbidol has been included in the NRDL in 2019.